Home / FANCM Knockout Cell Lines

FANCM Knockout Cell Lines

Gene: FANCM

Official Full Name: FA complementation group Mprovided by HGNC

Gene Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00186 FANCM Knockout cell line (HCT 116) Human FANCM 1:2~1:4 Negative Online Inquiry
KO20376 FANCM Knockout cell line (HeLa) Human FANCM 1:3~1:6 Negative Online Inquiry
KO20377 FANCM Knockout cell line (HEK293) Human FANCM 1:3~1:6 Negative Online Inquiry
KO20378 FANCM Knockout cell line (A549) Human FANCM 1:3~1:4 Negative Online Inquiry

Background

FANCM Gene Knockout Cell Lines are specialized cell lines engineered to lack functional FANCM (FANconi anemia complementation group M) protein, a pivotal component involved in DNA repair and maintenance. These cell lines serve as crucial tools for studying the cellular mechanisms underlying genomic stability, particularly in the context of DNA damage response and repair pathways. The absence of FANCM highlights its role in interstrand crosslink repair and identifies the cellular vulnerabilities that arise from compromised DNA repair mechanisms.

Key functions of FANCM include its involvement in the Fanconi anemia pathway, wherein it aids in recognizing and repairing DNA crosslinks through its recruitment to sites of damage. The knockout of this gene leads to increased sensitivity to genotoxic agents, allowing researchers to study its role in the pathogenesis of cancer, particularly in contexts where DNA repair is integral to tumorigenesis and therapeutic resistance.

In research and clinical applications, FANCM Gene Knockout Cell Lines are invaluable for drug screening, elucidating molecular pathways involved in cancer biology, and testing therapies aimed at enhancing DNA damage response. These cell lines help in identifying potential biomarkers for FANCM-related cancers, making them essential for personalized medicine and targeted therapies.

Compared to other existing models, our FANCM Gene Knockout Cell Lines offer unmatched specificity and reliability, characterized by rigorous validation and extensive background data. They are derived from well-characterized parental cell lines, ensuring consistent performance in experiments.

For researchers and clinicians, the value of these cell lines lies not only in their ability to elucidate the fundamental aspects of DNA repair but also in their potential to inform the development of innovative therapeutic strategies against cancers associated with faulty DNA repair mechanisms.

Our company specializes in producing high-quality biological products and is committed to advancing research through innovative solutions. With expertise in cellular engineering and a strong focus on customer collaboration, we strive to provide researchers with the tools they need to drive forward their scientific inquiries.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.